Randomized, double-blind, placebo-controlled trial of monthly injectable buprenorphine for methamphetamine use disorder (MURB) (CTN-0110)

NIH RePORTER · NIH · N01 · $1,406,983 · view on reporter.nih.gov ↗

Abstract

Randomized, double-blind, placebo-controlled trial of monthly injectable buprenorphine for methamphetamine use disorder (MURB) (CTN-0110)

Key facts

NIH application ID
10505738
Project number
75N95019D00013-0-759502100004-1
Recipient
THE EMMES COMPANY, LLC
Principal Investigator
Paul VanVeldhuisen
Activity code
N01
Funding institute
NIH
Fiscal year
2021
Award amount
$1,406,983
Award type
—
Project period
2021-07-01 → 2024-06-14